Alpine Immune Sciences Inc (ALPN)
64.60
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
64.60
0.00 (0.00%)
After-Hours: 20:00
Alpine Immune Sciences Total Liabilities (Quarterly): 51.91M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 51.91M |
| September 30, 2023 | 78.92M |
| June 30, 2023 | 83.45M |
| March 31, 2023 | 92.56M |
| December 31, 2022 | 107.27M |
| September 30, 2022 | 109.59M |
| June 30, 2022 | 116.29M |
| March 31, 2022 | 118.51M |
| December 31, 2021 | 135.00M |
| September 30, 2021 | 110.66M |
| June 30, 2021 | 115.99M |
| March 31, 2021 | 76.68M |
| December 31, 2020 | 81.93M |
| September 30, 2020 | 86.56M |
| June 30, 2020 | 86.47M |
| March 31, 2020 | 24.99M |
| December 31, 2019 | 24.62M |
| September 30, 2019 | 29.91M |
| June 30, 2019 | 24.67M |
| Date | Value |
|---|---|
| March 31, 2019 | 10.52M |
| December 31, 2018 | 10.28M |
| September 30, 2018 | 9.524M |
| June 30, 2018 | 6.577M |
| March 31, 2018 | 6.818M |
| December 31, 2017 | 6.305M |
| September 30, 2017 | 7.814M |
| June 30, 2017 | 3.578M |
| March 31, 2017 | 3.789M |
| December 31, 2016 | 6.499M |
| September 30, 2016 | 5.238M |
| June 30, 2016 | 5.873M |
| March 31, 2016 | 4.578M |
| December 31, 2015 | 4.419M |
| September 30, 2015 | 4.465M |
| June 30, 2015 | 6.123M |
| March 31, 2015 | 46.22M |
| December 31, 2014 | 44.30M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
24.62M
Minimum
Dec 2019
135.00M
Maximum
Dec 2021
81.89M
Average
86.47M
Median
Jun 2020
Total Liabilities (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | 5.150B |
| Eliem Therapeutics Inc | 2.87M |
| Regeneron Pharmaceuticals Inc | 7.378B |
| Vera Therapeutics Inc | 73.86M |
| Eyenovia Inc | 19.78M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 379.85M |
| Shareholders Equity (Quarterly) | 327.94M |
| Current Ratio | 7.862 |
| Net Debt Paydown Yield | 0.08% |